ISPOR Launches HEOR by Topic Microsite

Published Apr 2, 2024

Real-World Data, Clinical Outcomes, Digital Health, Health Technology Assessment, and Patient-Centered Research Among the Featured Topics

Lawrenceville, NJ, USA—April 2, 2024—ISPOR—The Professional Society for Health Economics and Outcomes Research (HEOR) announced today that it has launched a new microsite that provides HEOR information and resources organized by topical areas of interest—HEOR by Topic.

The field of HEOR focuses on a variety of diverse topical areas. ISPOR’s new HEOR by Topic microsite organizes the Society’s content by these areas and features valuable content from its conferences and summits, leading journal Value in Health, HEOR magazine Value & Outcomes Spotlight, and more. Featured HEOR topics include:

“We are excited to launch ISPOR’s new HEOR by Topic content,” stated ISPOR CEO and Executive Director, Rob Abbott. “This new microsite enhances the accessibility of resources by aggregating and organizing the Society’s content by topical interest.  These essential resources are available to anyone interested in the field of HEOR.”

In addition to the Society’s new HEOR by Topic microsite, additional information and resources can be found on ISPOR’s website, including:

About HEOR | Top 10 HEOR Trends Report | About Real-World Evidence | HEOR News Desk

###

 

ABOUT ISPOR
ISPOR—The Professional Society for Health Economics and Outcomes Research
(HEOR), is an international, multistakeholder, nonprofit dedicated to advancing HEOR excellence to improve decision making for health globally. The Society is the leading source for scientific conferences, peer-reviewed and MEDLINE®-indexed publications, good practices guidance, education, collaboration, and tools/resources in the field.
Website
 | LinkedIn  | Twitter (@ispororg)  |  YouTube  |  Facebook  |  Instagram  

Related Stories

The Ozempic Paradox: How Spending Billions on Weight-Loss Drug Would Actually Reduce Overall Medicare Costs

Oct 14, 2025

Value in Health, the official journal of ISPOR—The Professional Society for Health Economics and Outcomes Research, announced today the publication of a landmark study by researchers at the University of Washington, Curta, Inc, and the University of North Carolina showing that broad Medicare coverage of semaglutide in diabetes, obesity, and liver disease could generate significant cost savings while delivering substantial health benefits to beneficiaries. The report, “Comprehensive Access to Semaglutide: Clinical and Economic Implications for Medicare,” was published in the October 2025 issue of Value in Health.

ISPOR Europe 2025 Plenaries and Speakers Announced

Oct 13, 2025

ISPOR announced details for its ISPOR Europe 2025. The conference is the leading global conference in Europe for health economics and outcomes research (HEOR) and is scheduled for 9-12 November in Glasglow, Scotland, UK with the theme, “Powering Value and Access Through Patient-Centered Collaboration.”
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×